Lunai Bioworks raises $20M to acquire CNS delivery technology
Tweet Send to a Friend
Lunai Bioworks Inc. (NASDAQ: LNAI) completed a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


